These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 29515565)

  • 1. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
    Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
    J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
    Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
    Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity.
    Li Y; Mooney EC; Holden SE; Xia XJ; Cohen DJ; Walsh SW; Ma A; Sahingur SE
    J Immunol; 2019 Apr; 202(7):2044-2056. PubMed ID: 30760622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
    Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune regulation role of A20 and its clinical significance].
    Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.
    Crump KE; Oakley JC; Xia-Juan X; Madu TC; Devaki S; Mooney EC; Sahingur SE
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
    He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
    J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
    Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
    J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of A20 in autoimmune diseases.
    Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
    Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
    Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
    Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 in inflammation and autoimmunity.
    Catrysse L; Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2014 Jan; 35(1):22-31. PubMed ID: 24246475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ubiquitin-Modifying Enzyme A20 Terminates C-Type Lectin Receptor Signals and Is a Suppressor of Host Defense against Systemic Fungal Infection.
    Liang J; Zhang JJ; Huang HI; Kanayama M; Youssef N; Jin YJ; Reyes EY; Abram CL; Yang S; Lowell CA; Wang D; Shao L; Shinohara ML; Zhang JY; Hammer GE
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32540868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effect of polymorphisms in the promoter of TNFAIP3 (A20) in acute pancreatitis in the Han Chinese population.
    Liu Y; Dan G; Wu L; Chen G; Wu A; Zeng P; Xu W
    PLoS One; 2014; 9(7):e103104. PubMed ID: 25050625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
    He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Mutations Associated With TNFAIP3 (A20) Haploinsufficiency and Their Impact on Inflammatory Diseases.
    Bagyinszky E; An SSA
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the cytoplasmic ubiquitin ligase TNFAIP3 gene variation on transcription factor NF-κB activation in acute kidney injury.
    Rogers NM; Zammit N; Nguyen-Ngo D; Souilmi Y; Minhas N; Meijles DN; Self E; Walters SN; Warren J; Cultrone D; El-Rashid M; Li J; Chtanova T; O'Connell PJ; Grey ST
    Kidney Int; 2023 Jun; 103(6):1105-1119. PubMed ID: 37097268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.